IDO1 and neoplasm: In a series of tumor cell lines, it was demonstrated that constitutive IDO expression depends on COX2 and prostaglandin E2 (PGE2), which upon autocrine signaling through the EP receptor activates IDO transcription via the PKC and PI3K pathways.